Valuation: Aptamer Group PLC

Market Cap 1.73Cr 2.32Cr 2.02Cr 1.89Cr 3.26Cr 221.39Cr 3.3Cr 22Cr 8.67Cr 110.62Cr 8.73Cr 8.54Cr 368.17Cr P/E 2024
-0.91x
P/E 2025 -2.93x
Enterprise Value 1.67Cr 2.25Cr 1.95Cr 1.83Cr 3.15Cr 214.11Cr 3.2Cr 21Cr 8.39Cr 106.98Cr 8.44Cr 8.26Cr 356.07Cr EV / Sales 2024
3.47x
EV / Sales 2025 6.31x
Free-Float
75.57%
Yield 2024 *
-
Yield 2025 -
1 day-5.26%
1 week-5.26%
Current month-5.26%
1 month-5.26%
3 months-25.00%
6 months-51.35%
Current year-58.14%
1 week 0.43
Extreme 0.433
0.5
1 month 0.4
Extreme 0.4
0.55
Current year 0.4
Extreme 0.4
1.15
1 year 0.4
Extreme 0.4
1.57
3 years 0.2
Extreme 0.2
2.46
5 years 0.2
Extreme 0.2
157
10 years 0.2
Extreme 0.2
157
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 01/01/2008
Chief Executive Officer 48 14/08/2024
Director of Finance/CFO - 01/01/2022
Director TitleAgeSince
Director/Board Member 48 01/01/2008
Director/Board Member - 29/05/2014
Chairman 48 14/08/2024
Date Insider Type Main position Quantity % Market Cap.
09/09/25 Buy

Chairman

50,00,000 0.1879%
18/07/25 Free

Director

29,68,695 0.1491%
28/01/25 Free

Director

34,99,343 0.1760%
Change 5-day change 1-year change 3-year change Capi.($)
-5.26%-5.26%-7.22%-80.00% 2.21Cr
+0.77%+6.68%-23.93%+9.24% 3.47TCr
-1.19%+8.57%-43.73%+153.40% 1.33TCr
-1.19%-5.16%-24.66%+61.34% 543.84Cr
-0.24%+4.86% - - 234.32Cr
-4.42%-1.28% - - 185.75Cr
-2.54%-2.07%+16.89%-44.32% 169.05Cr
-2.36%+0.23%-36.83% - 104.48Cr
-2.60%+1.47%+28.96%+113.10% 91Cr
-0.27%+8.55%-38.26%-48.96% 85Cr
Average -1.93%+2.96%-16.10%+23.40% 621.15Cr
Weighted average by Cap. -0.22%+3.70%-26.95%+47.05%

Financials

2024 2025
Net sales 9L 11.57L 10.04L 9L 16.24L 11Cr 16.45L 1.1Cr 43.16L 5.51Cr 43.44L 42.5L 18Cr 12.03L 16.18L 14.04L 13.15L 22.71L 15Cr 23.01L 1.54Cr 60.38L 7.7Cr 60.76L 59.44L 26Cr
Net income -29.58L -39.79L -34.53L -32.34L -55.84L -38Cr -56.57L -3.78Cr -1.48Cr -19Cr -1.49Cr -1.46Cr -63Cr -24.24L -32.61L -28.3L -26.5L -45.76L -31Cr -46.36L -3.1Cr -1.22Cr -16Cr -1.22Cr -1.2Cr -52Cr
Net Debt -53T -71.3T -61.88T -57.94T -1L -67.92L -1L -7L -3L -33.94L -3L -3L -1.13Cr -6L -8L -7L -6L -10.72L -7.28Cr -10.86L -72.64L -28.51L -3.64Cr -28.69L -28.07L -12Cr
Logo Aptamer Group PLC
Aptamer Group plc is a United Kingdom-based global developer of aptamer-based ligands. The Company develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications. The Company's Optimer platform delivers aptamer tools that are enabling researchers and developers across the spectrum of the life sciences. Its Optimer binders have been developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Its Aptamer Diagnostics division uses the Company's technology to support the development of diagnostic platforms, such as proteomics, lateral flow devices, biosensors and immunoassays, such as enzyme-linked immunosorbent assay (ELISA).
Employees
30
Date Price Change Volume
06/26/06 GBX 0.4500 -5.26% 33,54,093
05/26/05 GBX 0.4750 0.00% 20,14,556
04/26/04 GBX 0.4750 0.00% 23,36,589
03/26/03 GBX 0.4750 0.00% 34,62,757
31/26/31 GBX 0.4750 0.00% 53,05,106

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APTA Stock